tiprankstipranks
Celadon Pharmaceuticals PLC (GB:CEL)
LSE:CEL
UK Market

Celadon Pharmaceuticals PLC (CEL) Share Price & Analysis

3 Followers

CEL Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range73.44p - 180.00p
Previous Close110p
Volume128.31K
Average Volume (3M)43.00K
Market Cap
£70.63M
Enterprise Value65.68M
Total Cash (Recent Filing)£9.08M
Total Debt (Recent Filing)£4.59M
Price to Earnings (P/E)-3.8
Beta-0.63
Apr 26, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding62,469,773
10 Day Avg. Volume11,316
30 Day Avg. Volume43,002
Standard Deviation0.47
R-Squared0.02
Alpha0.08
Financial Highlights & Ratios
Price to Book (P/B)26.10
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-11.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

3.91%0.00%0.00%96.09%
3.91%
Insiders
0.00% Other Institutional Investors
96.09% Public Companies and
Individual Investors

CEL FAQ

What was Celadon Pharmaceuticals PLC’s price range in the past 12 months?
Celadon Pharmaceuticals PLC lowest share price was 73.44p and its highest was 180.00p in the past 12 months.
    What is Celadon Pharmaceuticals PLC’s market cap?
    Currently, no data Available
    When is Celadon Pharmaceuticals PLC’s upcoming earnings report date?
    Celadon Pharmaceuticals PLC’s upcoming earnings report date is Apr 26, 2024 which is in 7 days.
      How were Celadon Pharmaceuticals PLC’s earnings last quarter?
      Currently, no data Available
      Is Celadon Pharmaceuticals PLC overvalued?
      According to Wall Street analysts Celadon Pharmaceuticals PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Celadon Pharmaceuticals PLC pay dividends?
        Celadon Pharmaceuticals PLC does not currently pay dividends.
        What is Celadon Pharmaceuticals PLC’s EPS estimate?
        Celadon Pharmaceuticals PLC’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Celadon Pharmaceuticals PLC have?
        Celadon Pharmaceuticals PLC has 64,208,900 shares outstanding.
          What happened to Celadon Pharmaceuticals PLC’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Celadon Pharmaceuticals PLC?
          Currently, no hedge funds are holding shares in GB:CEL
          ---

          Celadon Pharmaceuticals PLC Stock Smart Score

          Company Description

          Celadon Pharmaceuticals PLC

          Summerway Capital PLC operates as an investment holding company. It is focused on acquiring businesses that are either headquartered in the UK or that have substantial operations in the UK. The company is principally focused on opportunities in the wider household and consumer goods sector, including retail and consumer brands, particularly where there is an opportunity to introduce operational and performance improvements, including new technologies and associated operating and value leverage.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          HemoGenyx Pharmaceuticals Plc
          Destiny Pharma plc
          C4X Discovery Holdings
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis